Barclays
CORZ icon

Barclays’s Core Scientific CORZ Stock Holding History

Barclays’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.68M Buy
355,305
+172,348
+94% +$3.39M ﹤0.01% 1962
2026
Q2 		$4.68M Buy
182,957
+26,592
+17% +$626K ﹤0.01% 1886
2026
Q1 		$2.34M Sell
156,365
-788,172
-83% -$13.4M ﹤0.01% 2249
2025
Q4 		$13.8M Buy
944,537
+198,192
+27% +$3.46M ﹤0.01% 1460
2025
Q3 		$13.4M Buy
746,345
+9,561
+1% +$140K ﹤0.01% 1471
2025
Q2 		$12.6M Buy
736,784
+499,371
+210% +$5M ﹤0.01% 1408
2025
Q1 		$1.72M Sell
237,413
-788,154
-77% -$8.97M ﹤0.01% 2735
2024
Q4 		$14.4M Sell
1,025,567
-144,523
-12% -$2.14M ﹤0.01% 1305
2024
Q3 		$13.9M Buy
1,170,090
+433,855
+59% +$4.5M ﹤0.01% 1259
2024
Q2 		$6.85M Buy
736,235
+536,235
+268% +$2.74M ﹤0.01% 1357
2024
Q1 		$708K Buy
+200,000
New +$694K ﹤0.01% 3364

Other funds holding CORZ

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.81B AUM 16.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
ORG Wealth Partners
ORG Wealth Partners Dallas, Texas $607M AUM 23.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Barclays's CORZ Position: Q3 2026 in Review

Barclays increased its Core Scientific (CORZ) stake by 94% in Q3 2026, buying an estimated $3.39M and bringing the position to 355,305 shares worth $5.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Barclays first reported a position in CORZ in Q1 2024 and has held it in 11 quarters since. The position peaked at $14.4M in Q4 2024. 288 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • Barclays held 355,305 shares of Core Scientific worth $5.68M as of Q3 2026.
  • Barclays bought 172,348 Core Scientific shares in Q3 2026, an estimated $3.39M.
  • Core Scientific made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1962 holding.
  • Barclays first reported a position in Core Scientific in Q1 2024 and has held it in 11 quarters since.
  • Barclays's Core Scientific position peaked at $14.4M in Q4 2024.
  • 288 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.